Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Cervix (All Stages^), 2020

All Races (includes Hispanic), Female, All Ages

Sorted by Count

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Recent Trends - This is an interpretation of the AAPC/APC:

AAPC/APC (95% Confidence Interval) - the change in rate over time


Other Notes


Line by Line Interpretation of the Report


US (SEER+NPCR)1


North Dakota2


Wyoming2


Vermont2


District of Columbia2


South Dakota2


New Hampshire2


Delaware2


Idaho7


Montana2


Rhode Island2


Nebraska2


Hawaii7


Maine2


New Mexico7


West Virginia2


Utah7


Iowa7


Connecticut7


Kansas2


Arkansas2


Mississippi2


Oregon2


Minnesota2


Wisconsin2


Massachusetts7


Colorado2


Louisiana7


Puerto Rico2


Oklahoma2


Arizona2


Kentucky7


Maryland2


South Carolina2


Washington4


Alabama2


Missouri2


Tennessee2


Virginia2


Michigan2


New Jersey7


North Carolina2


Ohio2


Georgia7


Illinois7


Pennsylvania2


New York7


Florida2


Texas7


California7


Alaska2 Indiana2 Nevada2

Notes:
Created by statecancerprofiles.cancer.gov on 06/29/2024 9:44 am.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Alaska, Indiana, Nevada

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.
* Data has been suppressed to ensure confidentiality and stability of rate estimates. Counts are suppressed if fewer than 16 records were reported in a specific area-sex-race category. If an average count of 3 is shown, the total number of cases for the time period is 16 or more which exceeds suppression threshold (but is rounded to 3).
Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.
Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.